De-risking Drug Development Through Biological and Artificial Intelligence

Name: De-risking Drug Development Through Biological and Artificial Intelligence
Start: 2026-11-11T10:35
End: 2026-11-11T10:50
Location: Intercontinental Barcelona

Drug Discovery Chemistry Europe 2026 · 11 November 2026 · 10:35–10:50

De-risking Drug Development Through Biological and Artificial Intelligence was a session at Drug Discovery Chemistry Europe 2026 on 11 November 2026 in Barcelona, with 2 speakers on record.

Speakers

Fanny Jaulin — Speaker CEO & Cofounder, Orakl Oncology
Gustave Ronteix — Speaker Co-Founder and CTO, Orakl Oncology